These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2560690)

  • 1. Serum angiotensin converting enzyme activity in type 2 (non-insulin-dependent) diabetic patients with chronic glomerulonephritis.
    Ninomiya Y; Arakawa M
    Diabetes Res; 1989 Jul; 11(3):121-4. PubMed ID: 2560690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum angiotensin-converting enzyme activity and active renin plasma concentrations in insulin-dependent diabetes mellitus.
    Duntas L; Keck FS; Haug C; Hetzel W; Wolf CF; Rosenthal J; Pfeiffer EF
    Diabetes Res Clin Pract; 1992 Jun; 16(3):203-8. PubMed ID: 1330463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum angiotensin converting enzyme (S-ACE) activity in patients with chronic renal failure on regular hemodialysis.
    Miura H; Nakayama M; Sato T
    Jpn Heart J; 1984 Jan; 25(1):87-92. PubMed ID: 6330398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum angiotensin converting enzyme activity in type I insulin-dependent diabetes mellitus: its relation to metabolic control and diabetic complications.
    Van Dyk DJ; Erman A; Erman T; Chen-Gal B; Sulkes J; Boner G
    Eur J Clin Invest; 1994 Jul; 24(7):463-7. PubMed ID: 7957503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
    Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
    Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy.
    Ustündağ B; Canatan H; Cinkilinç N; Halifeoğlu I; Bahçecioğlu IH
    Cell Biochem Funct; 2000 Mar; 18(1):23-8. PubMed ID: 10686580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between serum angiotensin I-converting enzyme activity and diabetic nephropathy in patients with type II diabetes].
    Liao L; Lei M; Han X; Chen H; Fan C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):263-6. PubMed ID: 12016801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changes of serum angiotensin converting enzyme activity in Type 2 diabetes and its vascular complications].
    Wu H; Qu S; Zhang Y; Deng J; Li J; Zhou J
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):373-5. PubMed ID: 12545838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary type IV collagen as a marker for early diabetic nephropathy.
    Kado S; Aoki A; Wada S; Katayama Y; Kugai N; Yoshizawa N; Nagata N
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):103-8. PubMed ID: 8792108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The higher immunoreactivity to ACE (angiotensin converting enzyme) in patients with type 2 diabetes mellitus than in non-diabetic individuals.
    Nishida S; Nohno T; Hirokawa Y; Matsuki M; Tanaka J; Ichihara K
    Endocr J; 2003 Apr; 50(2):209-13. PubMed ID: 12803241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus.
    Boomsma F; Pedersen-Bjergaard U; Agerholm-Larsen B; Hut H; Dhamrait SS; Thorsteinsson B; van den Meiracker AH
    Diabetologia; 2005 May; 48(5):1002-7. PubMed ID: 15830186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of intrarenal angiotensin-converting enzyme in nephropathy of type II diabetic rats.
    Taniguchi M; Kim S; Zhan Y; Iwao H
    Hypertens Res; 2002 Mar; 25(2):287-94. PubMed ID: 12047045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IgA levels in patients with diabetic nephropathy and IgA nephropathy superimposed on diabetes mellitus.
    Kanauchi M; Kawano T; Dohi K
    Diabetes Res Clin Pract; 2000 May; 48(2):113-8. PubMed ID: 10802148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Mizuiri S; Hemmi H; Inoue A; Yoshikawa H; Tanegashima M; Fushimi T; Ishigami M; Amagasaki Y; Ohara T; Shimatake H
    Nephron; 1995; 70(4):455-9. PubMed ID: 7477652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.
    Rahimi Z; Felehgari V; Rahimi M; Mozafari H; Yari K; Vaisi-Raygani A; Rezaei M; Malek-Khosravi S; Khazaie H
    Mol Biol Rep; 2011 Mar; 38(3):2117-23. PubMed ID: 20853144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy.
    Mizuiri S; Yoshikawa H; Tanegashima M; Miyagi M; Kobayashi M; Sakai K; Hayashi I; Aikawa A; Ohara T; Hasegawa A
    Am J Kidney Dis; 1998 Feb; 31(2):301-7. PubMed ID: 9469501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.
    Huang XH; Rantalaiho V; Wirta O; Pasternack A; Hiltunen TP; Koivula T; Malminiemi K; Nikkari T; Lehtimäki T
    Nephron; 1998 Sep; 80(1):17-24. PubMed ID: 9730698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
    Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
    Kidney Int; 2002 Jul; 62(1):192-8. PubMed ID: 12081578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.